chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Right Shoulder Blade Swollen; Right arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Right Shoulder Blade Swollen) and VACCINATION SITE PAIN (Right arm pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Depression and Acid reflux (oesophageal). Concomitant products included SIMVASTATIN, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (HYZAAR) and GARLIC [ALLIUM SATIVUM] for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Right Shoulder Blade Swollen) and VACCINATION SITE PAIN (Right arm pain). At the time of the report, VACCINATION SITE SWELLING (Right Shoulder Blade Swollen) and VACCINATION SITE PAIN (Right arm pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medication included cinnamon vitamins. Treatment information was not provided.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19
Clinical narrative: Patient remained asymptomatic throughout the course of the infection;; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ASYMPTOMATIC COVID-19 (Patient remained asymptomatic throughout the course of the infection;) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Morbid obesity. Concurrent medical conditions included Hypertension.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASYMPTOMATIC COVID-19 (Patient remained asymptomatic throughout the course of the infection;). At the time of the report, ASYMPTOMATIC COVID-19 (Patient remained asymptomatic throughout the course of the infection;) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: She can't bear the pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (She can't bear the pain) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine headache.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN (She can't bear the pain) and HEADACHE (Headache). At the time of the report, PAIN (She can't bear the pain) and HEADACHE (Headache) outcome was unknown.            Other concomitant product use included medications for migraine headache. Treatment information included medication for headache.  Action taken with mRNA-1273 in response to the events was  not applicable.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Felt warm to the touch; itching; Redness; Swelling; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Felt warm to the touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and PYREXIA (Fever) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Felt warm to the touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and PYREXIA (Fever). At the time of the report, VACCINATION SITE WARMTH (Felt warm to the touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, SARS-CoV-2 test positive
Clinical narrative: test covid +; coughing; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing) and SARS-COV-2 TEST POSITIVE (test covid +) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced COUGH (coughing). On 09-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (test covid +). At the time of the report, COUGH (coughing) and SARS-COV-2 TEST POSITIVE (test covid +) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Fatigue, Headache, Pain in extremity
Clinical narrative: Fever; Arm Pain-Near Injection site; Swelling- Near Injection site; Headache; Fatigue; Redness- Near Injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), PAIN IN EXTREMITY (Arm Pain-Near Injection site), PERIPHERAL SWELLING (Swelling- Near Injection site), HEADACHE (Headache) and FATIGUE (Fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced PYREXIA (Fever), PAIN IN EXTREMITY (Arm Pain-Near Injection site), PERIPHERAL SWELLING (Swelling- Near Injection site), HEADACHE (Headache), FATIGUE (Fatigue) and ERYTHEMA (Redness- Near Injection site). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), PAIN IN EXTREMITY (Arm Pain-Near Injection site), PERIPHERAL SWELLING (Swelling- Near Injection site), HEADACHE (Headache), FATIGUE (Fatigue) and ERYTHEMA (Redness- Near Injection site) outcome was unknown. Fever - Temperature of 100.3F    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 100.3 Farad (High) 100.3F.         no concomitant medications are provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Fever; Arm Pain-Near Injection site; Swelling- Near Injection site; Headache; Fatigue; Redness- Near Injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), PAIN IN EXTREMITY (Arm Pain-Near Injection site), PERIPHERAL SWELLING (Swelling- Near Injection site), HEADACHE (Headache) and FATIGUE (Fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced PYREXIA (Fever), PAIN IN EXTREMITY (Arm Pain-Near Injection site), PERIPHERAL SWELLING (Swelling- Near Injection site), HEADACHE (Headache), FATIGUE (Fatigue) and ERYTHEMA (Redness- Near Injection site). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), PAIN IN EXTREMITY (Arm Pain-Near Injection site), PERIPHERAL SWELLING (Swelling- Near Injection site), HEADACHE (Headache), FATIGUE (Fatigue) and ERYTHEMA (Redness- Near Injection site) outcome was unknown. Fever - Temperature of 100.3F    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 100.3 Farad (High) 100.3F.         no concomitant medications are provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Skin mass, Swelling face
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of pruritus (both arms became itchy), peripheral swelling (swelling of both arms and chest), swelling face (puffy face) and skin mass (lumps under her face skin) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 001A21A) for COVID-19 immunization. No medical history reported. On Feb 28, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; unspecified dose. On Mar 4, 2021, patient experienced pruritus (both arms became itchy), peripheral swelling (swelling of both arms and chest), swelling face (puffy face) and skin mass (lumps under her face skin). At the time of the report, pruritus (both arms became itchy), peripheral swelling (swelling of both arms and chest), swelling face (puffy face) and skin mass (lumps under her face skin) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Dizziness/ dizziness has caused him to step off of the curb sidewalk; World is spinning; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness/ dizziness has caused him to step off of the curb sidewalk) and VERTIGO (World is spinning) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Parkinson's disease. Concurrent medical conditions included Drug hypersensitivity (Pseudoephedrine). Concomitant products included RASAGILINE MESYLATE (AZILECT) and CARBIDOPA, LEVODOPA (CARBIDOPA LEVODOPA) for Parkinson's disease, LEVOTHYROXINE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DIZZINESS (Dizziness/ dizziness has caused him to step off of the curb sidewalk) and VERTIGO (World is spinning). At the time of the report, DIZZINESS (Dizziness/ dizziness has caused him to step off of the curb sidewalk) and VERTIGO (World is spinning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Decreased appetite, Diarrhoea, Fatigue
Clinical narrative: weak; lack of appetite; Body aches; felt tired; temperature of 99.7; Diarrhea; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ASTHENIA (weak), DECREASED APPETITE (lack of appetite), MYALGIA (Body aches) and VOMITING (vomiting) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (vomiting) and NAUSEA (Nausea). On 08-Mar-2021, the patient experienced ASTHENIA (weak), DECREASED APPETITE (lack of appetite), MYALGIA (Body aches), FATIGUE (felt tired) and PYREXIA (temperature of 99.7). At the time of the report, DIARRHOEA (Diarrhea), ASTHENIA (weak), DECREASED APPETITE (lack of appetite), MYALGIA (Body aches), VOMITING (vomiting), FATIGUE (felt tired), NAUSEA (Nausea) and PYREXIA (temperature of 99.7) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 99.7 (Inconclusive) Patient had a temperature of 99.7..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient were not provided. Treatment information was not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: weak; lack of appetite; Body aches; felt tired; temperature of 99.7; Diarrhea; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ASTHENIA (weak), DECREASED APPETITE (lack of appetite), MYALGIA (Body aches) and VOMITING (vomiting) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (vomiting) and NAUSEA (Nausea). On 08-Mar-2021, the patient experienced ASTHENIA (weak), DECREASED APPETITE (lack of appetite), MYALGIA (Body aches), FATIGUE (felt tired) and PYREXIA (temperature of 99.7). At the time of the report, DIARRHOEA (Diarrhea), ASTHENIA (weak), DECREASED APPETITE (lack of appetite), MYALGIA (Body aches), VOMITING (vomiting), FATIGUE (felt tired), NAUSEA (Nausea) and PYREXIA (temperature of 99.7) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 99.7 (Inconclusive) Patient had a temperature of 99.7..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient were not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Oral pain, Pruritus
Clinical narrative: Itching on left arm; Sore inside mouth; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), ORAL PAIN (Sore inside mouth) and PRURITUS (Itching on left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). On 05-Mar-2021, the patient experienced ORAL PAIN (Sore inside mouth). On 07-Mar-2021, the patient experienced PRURITUS (Itching on left arm). At the time of the report, HERPES ZOSTER (Shingles), ORAL PAIN (Sore inside mouth) and PRURITUS (Itching on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Dysgeusia, Erythema, Headache, Hypoaesthesia oral
Clinical narrative: redness; weird feeling in his mouth; lip numbness; loss of taste; sore arm; taste like copper; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), ORAL DISCOMFORT (weird feeling in his mouth), HYPOAESTHESIA ORAL (lip numbness), AGEUSIA (loss of taste) and PAIN IN EXTREMITY (sore arm) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ERYTHEMA (redness), ORAL DISCOMFORT (weird feeling in his mouth), HYPOAESTHESIA ORAL (lip numbness), AGEUSIA (loss of taste), PAIN IN EXTREMITY (sore arm), DYSGEUSIA (taste like copper) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (redness), ORAL DISCOMFORT (weird feeling in his mouth), HYPOAESTHESIA ORAL (lip numbness), AGEUSIA (loss of taste), PAIN IN EXTREMITY (sore arm), DYSGEUSIA (taste like copper) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Oral discomfort, Pain in extremity
Clinical narrative: redness; weird feeling in his mouth; lip numbness; loss of taste; sore arm; taste like copper; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), ORAL DISCOMFORT (weird feeling in his mouth), HYPOAESTHESIA ORAL (lip numbness), AGEUSIA (loss of taste) and PAIN IN EXTREMITY (sore arm) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ERYTHEMA (redness), ORAL DISCOMFORT (weird feeling in his mouth), HYPOAESTHESIA ORAL (lip numbness), AGEUSIA (loss of taste), PAIN IN EXTREMITY (sore arm), DYSGEUSIA (taste like copper) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (redness), ORAL DISCOMFORT (weird feeling in his mouth), HYPOAESTHESIA ORAL (lip numbness), AGEUSIA (loss of taste), PAIN IN EXTREMITY (sore arm), DYSGEUSIA (taste like copper) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Ear pain, Lymphadenopathy, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: positive Covid-19 test; sore throat; ear ache; swollen lymph node in neck; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), EAR PAIN (ear ache), LYMPHADENOPATHY (swollen lymph node in neck) and COVID-19 (positive Covid-19 test) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 06-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), EAR PAIN (ear ache) and LYMPHADENOPATHY (swollen lymph node in neck).   On 07-Mar-2021, the patient experienced COVID-19 (positive Covid-19 test). At the time of the report, OROPHARYNGEAL PAIN (sore throat), EAR PAIN (ear ache), LYMPHADENOPATHY (swollen lymph node in neck) and COVID-19 (positive Covid-19 test) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Nausea, Pain in extremity
Clinical narrative: Arm extremely hurt; Could not sleep; Nauseous/ Queasy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm extremely hurt), INSOMNIA (Could not sleep) and NAUSEA (Nauseous/ Queasy) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm extremely hurt), INSOMNIA (Could not sleep) and NAUSEA (Nauseous/ Queasy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 07-Mar-2021, PAIN IN EXTREMITY (Arm extremely hurt), INSOMNIA (Could not sleep) and NAUSEA (Nauseous/ Queasy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Includes Acetaminophen.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of arthralgia (excruciating joint pains: wrists and hips) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# unknown) for COVID-19 immunization. No medical history reported. On Feb 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 26, 2021, patient experienced arthralgia (excruciating joint pains: wrists and hips). The patient treated with Advil (ibuprofen), at an unspecified dose and frequency. At the time of the report, arthralgia (excruciating joint pains: wrists and hips): resolving. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Treatment of the events included ibuprofen.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Skin mass
Clinical narrative: lump on top part of her left chest; Normal pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Normal pain) and SKIN MASS (lump on top part of her left chest) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (Normal pain). On an unknown date, the patient experienced SKIN MASS (lump on top part of her left chest). At the time of the report, PAIN (Normal pain) and SKIN MASS (lump on top part of her left chest) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no treatment medication were provided. concomitants were not provided
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash all over the body; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of RASH (rash all over the body) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Mar-2021, the patient experienced RASH (rash all over the body). At the time of the report, RASH (rash all over the body) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain in extremity, Pruritus
Clinical narrative: itching in arm 2 Weeks after Vaccine; soreness in arm/ arm was sore for 2 days; nerve pain; This spontaneous pregnancy case was reported by a patient and describes the occurrence of PRURITUS (itching in arm 2 Weeks after Vaccine), PAIN IN EXTREMITY (soreness in arm/ arm was sore for 2 days) and NEURALGIA (nerve pain) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included LEVOTHYROXINE and METOPROLOL TARTRATE for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced PRURITUS (itching in arm 2 Weeks after Vaccine), PAIN IN EXTREMITY (soreness in arm/ arm was sore for 2 days) and NEURALGIA (nerve pain). At the time of the report, PRURITUS (itching in arm 2 Weeks after Vaccine), PAIN IN EXTREMITY (soreness in arm/ arm was sore for 2 days) and NEURALGIA (nerve pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: Pain at injection site; Pain at shoulder; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) and ARTHRALGIA (Pain at shoulder) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and ARTHRALGIA (Pain at shoulder). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE PAIN (Pain at injection site) and ARTHRALGIA (Pain at shoulder) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced HERPES ZOSTER (shingles). The patient was treated with CHLORAMPHENICOL (ANTIBIOTIC [CHLORAMPHENICOL]) for Shingles, at an unspecified dose and frequency.   At the time of the report, HERPES ZOSTER (shingles) had not resolved. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medications were not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain, Tenderness
Clinical narrative: soreness/ Pain; redness; tenderness; This spontaneous case was reported by a patient and describes the occurrence of PAIN (soreness/ Pain), ERYTHEMA (redness) and TENDERNESS (tenderness) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (soreness/ Pain), ERYTHEMA (redness) and TENDERNESS (tenderness). At the time of the report, PAIN (soreness/ Pain), ERYTHEMA (redness) and TENDERNESS (tenderness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic function abnormal, Liver function test
Clinical narrative: elevated liver function test; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC FUNCTION ABNORMAL (elevated liver function test) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 immunisation.     The patient's past medical history included Liver function test increased since 1989. Previously administered products included for an unreported indication: HEPATITIS B VACCIN (Hep B vaccine allergy years ago). Concomitant products included URSODEOXYCHOLIC ACID (URSO [URSODEOXYCHOLIC ACID]).  On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Mar-2021, the patient experienced HEPATIC FUNCTION ABNORMAL (elevated liver function test). At the time of the report, HEPATIC FUNCTION ABNORMAL (elevated liver function test) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Liver function test: increase (High) Increase.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasal congestion, Pyrexia, Rhinorrhoea
Clinical narrative: Nasal congestion; Cough; tested positive for COVID-19; Sneezing; Runny nose; low grade fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for COVID-19), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), NASAL CONGESTION (Nasal congestion) and COUGH (Cough) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and PYREXIA (low grade fever). On 05-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19). On 09-Mar-2021, the patient experienced NASAL CONGESTION (Nasal congestion) and COUGH (Cough). At the time of the report, COVID-19 (tested positive for COVID-19), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), NASAL CONGESTION (Nasal congestion), COUGH (Cough) and PYREXIA (low grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: Nasal congestion; Cough; tested positive for COVID-19; Sneezing; Runny nose; low grade fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for COVID-19), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), NASAL CONGESTION (Nasal congestion) and COUGH (Cough) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and PYREXIA (low grade fever). On 05-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19). On 09-Mar-2021, the patient experienced NASAL CONGESTION (Nasal congestion) and COUGH (Cough). At the time of the report, COVID-19 (tested positive for COVID-19), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), NASAL CONGESTION (Nasal congestion), COUGH (Cough) and PYREXIA (low grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis, Spinal pain, Vaccination site pain, Visual impairment
Clinical narrative: sharp pain at his spine where he had a surgery years ago and is not bothering him for years but; having a hard time seeing properly; having a hard time hearing properly; extreme pain at his injection arm; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (sharp pain at his spine where he had a surgery years ago and is not bothering him for years but), VISUAL IMPAIRMENT (having a hard time seeing properly), HYPOACUSIS (having a hard time hearing properly) and VACCINATION SITE PAIN (extreme pain at his injection arm) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0271A211A) for COVID-19 vaccination.     Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and OMEPRAZOLE for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SPINAL PAIN (sharp pain at his spine where he had a surgery years ago and is not bothering him for years but), VISUAL IMPAIRMENT (having a hard time seeing properly), HYPOACUSIS (having a hard time hearing properly) and VACCINATION SITE PAIN (extreme pain at his injection arm). At the time of the report, SPINAL PAIN (sharp pain at his spine where he had a surgery years ago and is not bothering him for years but), VISUAL IMPAIRMENT (having a hard time seeing properly), HYPOACUSIS (having a hard time hearing properly) and VACCINATION SITE PAIN (extreme pain at his injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant- Aderal 45mg
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Paraesthesia, Pyrexia
Clinical narrative: Swollen Lymph Nodes Near the Injection Site; Fatigue; Chills; Fever - Temperature of 101.0F; Tingling Sensation Under Skin; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling Sensation Under Skin), VACCINATION SITE LYMPHADENOPATHY (Swollen Lymph Nodes Near the Injection Site), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.0F) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PARAESTHESIA (Tingling Sensation Under Skin), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.0F). On 02-Mar-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swollen Lymph Nodes Near the Injection Site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Mar-2021, PARAESTHESIA (Tingling Sensation Under Skin), VACCINATION SITE LYMPHADENOPATHY (Swollen Lymph Nodes Near the Injection Site), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.0F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Body temperature: 101 (High) 101 degrees Fahrenheit.         No concomitant medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site lymphadenopathy
Clinical narrative: Swollen Lymph Nodes Near the Injection Site; Fatigue; Chills; Fever - Temperature of 101.0F; Tingling Sensation Under Skin; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling Sensation Under Skin), VACCINATION SITE LYMPHADENOPATHY (Swollen Lymph Nodes Near the Injection Site), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.0F) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PARAESTHESIA (Tingling Sensation Under Skin), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.0F). On 02-Mar-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swollen Lymph Nodes Near the Injection Site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Mar-2021, PARAESTHESIA (Tingling Sensation Under Skin), VACCINATION SITE LYMPHADENOPATHY (Swollen Lymph Nodes Near the Injection Site), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever - Temperature of 101.0F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Body temperature: 101 (High) 101 degrees Fahrenheit.         No concomitant medications were reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Pruritus, Swelling
Clinical narrative: spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed; itchy; swollen; hot to touch; red; Nickel sized, swollen red area; Nickel sized, swollen red area; first 3 days only sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area), VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PAIN IN EXTREMITY (first 3 days only sore arm) and ERYTHEMA (red) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (first 3 days only sore arm). On 07-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area) and ERYTHEMA (red). On 08-Mar-2021, the patient experienced VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PRURITUS (itchy), SWELLING (swollen) and FEELING HOT (hot to touch). At the time of the report, VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area), VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PAIN IN EXTREMITY (first 3 days only sore arm), ERYTHEMA (red), PRURITUS (itchy), SWELLING (swollen) and FEELING HOT (hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site reaction, Vaccination site swelling
Clinical narrative: spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed; itchy; swollen; hot to touch; red; Nickel sized, swollen red area; Nickel sized, swollen red area; first 3 days only sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area), VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PAIN IN EXTREMITY (first 3 days only sore arm) and ERYTHEMA (red) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (first 3 days only sore arm). On 07-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area) and ERYTHEMA (red). On 08-Mar-2021, the patient experienced VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PRURITUS (itchy), SWELLING (swollen) and FEELING HOT (hot to touch). At the time of the report, VACCINATION SITE SWELLING (Nickel sized, swollen red area), VACCINATION SITE ERYTHEMA (Nickel sized, swollen red area), VACCINATION SITE REACTION (spread half way across their arm horizontally about 4inches in width, and 3 inches in height patient state the area is red itchy and very inflamed), PAIN IN EXTREMITY (first 3 days only sore arm), ERYTHEMA (red), PRURITUS (itchy), SWELLING (swollen) and FEELING HOT (hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Drug screen, Urine analysis abnormal
Clinical narrative: Urine test positive for methadone; This spontaneous case was reported by a consumer and describes the occurrence of URINE ANALYSIS ABNORMAL (Urine test positive for methadone) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Arthritis and Hypokalemia. Concomitant products included TRAMADOL, MELOXICAM, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE (KLOR-CON M10) and AMLODIPINE for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced URINE ANALYSIS ABNORMAL (Urine test positive for methadone). At the time of the report, URINE ANALYSIS ABNORMAL (Urine test positive for methadone) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Drug screen: positive for methadone (Positive) positive for methadone..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Nausea, Pain, Pyrexia
Clinical narrative: chills; aching; like a bad flu; his left testicle swollen; his left is painful when you touch it; nausea; he had fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), PYREXIA (he had fever), CHILLS (chills), PAIN (aching) and INFLUENZA LIKE ILLNESS (like a bad flu) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced NAUSEA (nausea), PYREXIA (he had fever), PAIN (aching), INFLUENZA LIKE ILLNESS (like a bad flu), TESTICULAR SWELLING (his left testicle swollen) and TESTICULAR PAIN (his left is painful when you touch it). On an unknown date, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Mar-2021, NAUSEA (nausea), PYREXIA (he had fever), PAIN (aching), INFLUENZA LIKE ILLNESS (like a bad flu) and TESTICULAR SWELLING (his left testicle swollen) outcome was unknown. At the time of the report, CHILLS (chills) and TESTICULAR PAIN (his left is painful when you touch it) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        no concomitant medication provided